Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

Author(s):
Unruh, D.; Unlu, B.; Lewis, C.S.; Qi, X.Y.; Chu, Z.T.; Sturm, R.; Keil, R.; Ahmad, S.A.; Sovershaev, T.; Adam, M.; Dreden, P. van; Woodhams, B.J.; Ramchandani, D.; Weber, G.F.; Rak, J.W.; Wolberg, A.S.; Mackman, N.; Versteeg, H.H. (0000-0003-4294-175X); Bogdanov, V.Y.
Published
2016
Publication type
Article / Letter to editor
pancreatic cancertissue factoralternative splicingbeta 1 integrinsmetastasis
Date issued
2016-05-03
Language
English
Is part of
Oncotarget (2016), Vol. 7, no. 18, p. 25264-25275
hdl
1887/114052
doi
10.18632/oncotarget.7955